Panel Discussion: Reflecting on the Past Year- Discussing Current Radiopharmaceutical Trends & Assessing Our Progress
Time: 8:30 am
day: Conference Day One
Details:
- Exploring PSMA updates and predictions for the future market of prostate cancer drugs
- Pricing and reimbursement considerations in a competitive market
- Discussing key future commercial challenges and opportunities for the field from advances in manufacturing to competitive demand and selection of radioisotopes, with emphasis on actinium-225, lead-212, copper-64
